The Hydra-Headed Coronaviruses: Implications of COVID-19 for Homeopathy

Abstract

Successful homeopathic prescriptions are based on careful individualization of symptoms, either for an individual patient or collectively in the case of epidemic outbreaks. The ongoing COVID-19 pandemic was initially represented as a severe acute respiratory illness, with eventual dramatic complications. However, over time it revealed to be a complex systemic disease with manifestations derived from viral-induced inflammation and hypercoagulability, thus liable to affect any body organ or system. As a result, clinical presentation is variable, in addition to variations associated with several individual and collective risk factors. Given the extreme variability of pathology and clinical manifestations, a single, or a few, universal homeopathic preventive Do not split medicine(s) do not seem feasible. Yet homeopathy may have a relevant role to play, inasmuch as the vast majority of patients only exhibit the mild form of disease and are indicated to self-care at home, without standard monitoring, follow-up, or treatment. For future pandemics, homeopathy agencies should prepare by establishing rapid-response teams and efficacious lines of communication.

Keywords

coronavirus diseases - homeopathy - therapeutic approaches - complex pandemics

Highlights

• COVID-19 was originally represented as an acute severe respiratory disease.

• In time it has proved to be a complex systemic condition liable to affect any body organ or system.

• As a result, it exhibits a complex scope of pathology and clinical manifestations.

• The complex nature of COVID-19 does not seem amenable to the genus epidemicus approach in homeopathy.

• References

• 1 Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 2020 . Doi: 10.1111/jth.14849
• 2 Negri EM, Piloto BM, Morinaga LK. , et al. Heparin Therapy Improving Hypoxia in COVID-19 Patients: A Case Series. NY: medRχiv; 2020. . Preprint Doi: 10.1101/2020.04.15.20067017
• 3 Dohlnikoff M, Duarte-Neto AN, Monteiro RAA. , et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost 2020; 18: 1517-1519
• 4 Woodyatt A, Howard J. Coronavirus could be tied to a rare but serious illness in children, UK doctors say. CNN. 27 Apr 2020 18:43 GMT. Available at: https://edition.cnn.com/2020/04/27/health/children-covid-19-illness-intl-scli-gbr/index.html . Accessed April 29, 2020
• 5 Cheng M. European doctors warn rare kids' syndrome may have coronavírus tie. USA Today. Available at: https://www.usatoday.com/story/news/world/2020/04/28/coronavirus-doctors-warn-kawasaki-disease-may-have-covid-19-tie/3038537001/ . Accessed April 29, 2020
• 6 Reuters. Italy, UK explore possible COVID-19 link to Kawasaki disease in children. Available at: https://www.jpost.com/international/italy-uk-explore-possible-covid-19-link-to-kawasaki-disease-in-children-626133 . Accessed April 29, 2020
• 7 Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis 2005; 191: 499-502
• 8 Elkind E. Pediatrician explains why she's “not surprised” the coronavirus is being linked to a rare disease in children. CBS News. Available at: https://www.cbsnews.com/news/coronavirus-kawasaki-rare-disease-children-pediatrician-dyan-hes/ . Accessed April 29, 2020
• 9 Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395: 1033-1034
• 10 China National Health Commission. Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment. 7th ed. Available from American College of Cardiology. Available at: https://www.acc.org/latest-in-cardiology/articles/2020/03/17/11/22/chinese-clinical-guidance-for-covid-19-pneumonia-diagnosis-and-treatment . Accessed April 29, 2020
• 11 LMHI Executive Committee Communication Regarding Corona virus Epidemic. Available at: http://www.lmhi.org/Home/Corona . Accessed April 29, 2020
• 12 Central Council for Research in Homoeopathy. Ministry of AYUSH. Government of India. Homoeopathic perspectives in COVID-19 coronavirus infection. Available at: https://www.ccrhindia.nic.in/WriteReadData/LINKS/Coronavirus%20factsheet%2001b7d849-cd23-4d26-b520-685cba275c38.pdf . Accessed April 29, 2020
• 13 Associação Médica Homeopática Brasileira. Estudo preliminar de sintomas e medicamentos prevalentes do “gênio epidêmico” da pandemia. Available at: https://amhb.org.br/wp-content/uploads/2020/04/Estudo-Preliminar-do-Ge%CC%82nio-Epide%CC%82mico-capa-e-timbre-AMHB.pdf . Accessed April 29, 2020
• 14 Jacobs J. Homeopathic prevention and management of epidemic diseases. Homeopathy 2018; 107: 157-160
• 15 Waisse S. The science of high dilutions in historical context. Homeopathy 2012; 101: 129-137
• 16 Nunes LAS. Homeopathy and dengue: Macaé, Rio de Janeiro, Brazil, 2007–2012. Rev Homeopatia 2016; 79: 1-16
• 17 Prass-Santos C, Brina NT, Magalhães IL. , et al. Report on the use of homeopathic medication in the prophylaxis of dengue in Belo Horizonte, Minas Gerais, Brazil, in 2010. Rev Homeopatia 2012; 75: 1-12
• 18 Bracho G, Varela E, Fernández R. , et al. Large-scale application of highly-diluted bacteria for leptospirosis epidemic control. Homeopathy 2010; 99: 156-166
• 19 Hahnemann S. Heilung und Verhütung des Scharlach-Fiebers. In: Schmidt JM, Kaiser D. , eds. Samuel Hahnemann: Gesammelte kleine Schriften. Heidelberg: Karl F. Haug; 2001: 299-311
• 20 Hahnemann S. Organon of Medicine. 6th ed. New Delhi: B. Jain; 2005: §100
• 21 Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol 2020 . Doi: 10.1002/jmv25748
• 22 Xu YH, Dong JH, An WM. , et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect 2020; 80: 394-400
• 23 Wu Z, McGoogan JM. Characteristics and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239-1242
• 24 Johns Hopkins ABC. Guide. Coronavirus COVID-19 (SARS-CoV-2). Available at: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540747/all/Coronavirus_COVID_19__SARS_CoV_2_ . Accessed April 29, 2020
• 25 Hahnemann S. Organon of Medicine. 6th ed. New Delhi: B. Jain Publishers; 2005: §§102 , 241
• 26 Kasariyans A, Sankaran R. Homeopathy for coronavírus COVID-19 infection. Available at: https://hpathy.com/homeopathy-papers/homeopathy-for-coronavirus-covid-19-infection
• 27 Itajaí distribui a partir de quarta-feira homeopatia para melhorar imunidade. O Globo, 28 April 2020. Available at: https://g1.globo.com/sc/santa-catarina/noticia/2020/04/28/itajai-distribuia-partir-de-quarta-feira-homeopatia-para-melhorar-imunidade.ghtml . Accessed April 29, 2020
• 28 Kent JT. Lectures on Homoeopathic Philosophy. Chicago: Ehrhart & Karl; 1919
• 29 Huang C, Wang Y, Li X. , et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506
• 30 Chen N, Zhou M, Dong X. , et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-513
• 31 Guan WJ, Ni ZY, Hu Y. , et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-1720
• 32 Wang D, Hu B, Hu C. , et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061-1069
• 33 World Health Organization. Global surveillance for COVID-19 caused by human infection with COVID-19 virus. Interim guidance. 20 March 2020. Available at: https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov . Accessed April 29, 2020
• 34 Fang Z, Yi F, Wu K. , et al. Clinical Characteristics of Coronavirus Disease 2019 (COVID-19); An Updated Systematic Review. NY: medRχiv; 2020. . Preprint Doi: 10.1101/2020.03.07.20032573
• 35 Sun P, Qie S, Liu Z. , et al. Clinical characteristics of 50466 patients with 2019-nCoV infection.. NY: medRχiv; 2020. . Preprint Doi: 10.1101/2020.02.18.20024539
• 36 Tang C, Zhang K, Wang W. , et al. Clinical characteristics of 20,662 patients with COVID-19 in Mainland China: a systemic review and meta-analysis. NY: medRχiv; 2020. . Preprint Doi: 10.1101/2020.04.18.20070565
• 37 Heydari K, Rismantab S, Shamshirian A. , et al. Clinical and paraclinical characteristics of COVID-19 patients: a systematic review and meta-analysis. NY: medRχiv; 2020. . Preprint Doi: 10.1101/2020.03.26.20044057
• 38 Aguilar RB, Hardigan P, Mayi B. , et al. Current understanding of COVID-19 clinical course and investigational treatments. NY: medRχiv; 2020. . Preprint Doi: 10.1101/2020.04.19.20071548
• 39 Couzin-Frankel J. The mystery of the pandemic's ‘happy hypoxia’. Science 2020; 368: 455-456
• 40 Gattinoni L, Chiumello D, Caironi P. , et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes?. Intensive Care Med 2020; 46: 1099-1102
• 41 Li R, Pei S, Chen B. , et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 2020; 368: 489-493
• 42 Mao L, Jin H, Wang M. , et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683-690
• 43 Li Y, Wang M, Zhou Y. , et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Lancet–preprints (SSRN) 2020 Doi: 10.2139/ssrn.3550025
• 44 Vetter P, Vu DL, L'Huillier AG, Schibler M, Kaiser L, Jacquerioz F. Clinical features of covid-19. BMJ 2020; 369: m1470
• 45 Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020 Doi: 10.1148/radiol.2020201187
• 46 Bernard-Valet R, Pizzarotti B, Anichini A. , et al. Two Patients with Acute Meningo-encephalitis Concomitant to SARS-CoV-2 Infection. NY: medRχiv; 2020. Preprint Doi: 10.1101/2020.04.17.20060251
• 47 Zhang T, Rodricks MB, Hirsh E. COVID-19-Associated Acute Disseminated Encephalomyelitis—A Case Report. NY: medRχiv; 2020. . Preprint Doi: 10.1101/2020.04.16.20068148;
• 48 Oxley TJ, Mocco J, Majidi S. , et al. Large-vessel stroke as a presenting feature of COVID-19 in the young. N Engl J Med 2020; 382: e60
• 49 Wu P, Duan F, Luo C. , et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020; 138: 575-578
• 50 Zhang X, Chen X, Chen L. , et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf 2020; 18: 360-362
• 51 Beltrán-Corbellini Á, Chico-García JL, Martínez-Poles J, Rodríguez-Jorge F, Alonso-Cánovas A. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study. Eur J Neurol 2020 . Doi: 10.1111/ene.14273
• 52 US Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). Symptoms of coronavirus. Available at: https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html . Accessed April 29, 2020
• 53 Shi S, Qin M, Shen B. , et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020 . Doi: 10.1001/jamacardio.2020.0950
• 54 Guo T, Fan Y, Chen M. , et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020 . Doi: 10.1001/jamacardio.2020.1017
• 55 Yang C, Jin Z. An acute respiratory infection runs into the most common noncommunicable epidemic—COVID-19 and cardiovascular diseases. JAMA Cardiol 2020 . Doi: 10.1001/jamacardio.2020.0934
• 56 Inciardi RM, Lupi L, Zaccone G. , et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020 . Doi: 10.1001/jamacardio.2020.1096
• 57 An P, Chen H, Jiang X. , et al. Clinical features of 2019 novel coronavirus pneumonia presented gastrointestinal symptoms but without fever onset. Lancet–Preprints (SSRN) 2020 Doi: 10.2139/ssrn.3532530
• 58 Han C, Duan C, Zhang S. , et al. Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am J Gastroenterol 2020; 115: 916-923
• 59 Pan L, Mu M, Yang P. , et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol 2020; 115: 766-773
• 60 Fan Z, Chen L, Li J. , et al. Clinical features of COVID-19-related liver functional abnormality. Clin Gastroenterol Hepatol 2020; 18: 1561-1566
• 61 Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int 2020 Doi: 10.1111/liv.14455
• 62 Feng Z, Diao B, Wang R. , et al. The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes. NY: medRχiv; 2020. . Preprint Doi: 10.1101/2020.03.27.20045427
• 63 Tosato F, Giraudo C, Pelloso M, Musso G, Piva E, Plebani M. One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients. Clin Chem Lab Med 2020; 58: 1149-1151
• 64 Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17: 181-192
• 65 Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004; 203: 631-637
• 66 Hamming I, Cooper ME, Haagmans BL. , et al. The emerging role of ACE2 in physiology and disease. J Pathol 2007; 212: 1-11
• 67 The Lancet. Editorial. The gendered dimensions of COVID-19. Lancet 2020; 395: 1168
• 68 Government of India. Press Information Bureau. AYUSH. Advisory for corona virus. Available at: https://pib.gov.in/PressReleasePage.aspx?PRID=1600895 . Accessed April 30, 2020
• 69 INFOMED. Homeopatía y la aprobación del PrevengHo®Vir. Available at: https://temas.sld.cu/coronavirus/2020/04/08/homeopatia-y-la-aprobacion-del-prevenghovir/ . Accessed April 30, 2020
• 70 Brazil. Municipal Government of Betim, Minas Gerais. Homeopatia é aliada contra a COVID-19 em Betim. Available at: http://www.betim.mg.gov.br/noticias/43963%3B50103%3B06%3B9808%3B184295.asp . Accessed May 13, 2020
• 71 Clinical Trials Registry – India. Proving the efficacy of homeopathic treatment in prevention and cure of COVID-19. Available at: https://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212&EncHid=&userName=homeopathy . Accessed May 13, 2020